benzbromarone has been researched along with Alloxan Diabetes in 1 studies
Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thounaojam, MC | 1 |
| Montemari, A | 1 |
| Powell, FL | 1 |
| Malla, P | 1 |
| Gutsaeva, DR | 1 |
| Bachettoni, A | 1 |
| Ripandelli, G | 1 |
| Repossi, A | 1 |
| Tawfik, A | 1 |
| Martin, PM | 1 |
| Facchiano, F | 1 |
| Bartoli, M | 1 |
1 other study available for benzbromarone and Alloxan Diabetes
| Article | Year |
|---|---|
Monosodium Urate Contributes to Retinal Inflammation and Progression of Diabetic Retinopathy.
Topics: Allopurinol; Animals; Benzbromarone; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Humans; | 2019 |